
Bayer Pursues Capital Raise Amidst Ongoing Legal Challenges
Bayer AG, the German pharmaceutical giant, is taking significant steps to manage its extensive legal challenges by seeking regulatory approval for a substantial capital increase. This decision comes as the company continues to face the financial repercussions from various lawsuits related to its herbicide Roundup, which has been linked to cancer claims.
Continue reading
Bayer Ordered to Pay $100 Million Over Toxic PCB Contamination
In a significant legal blow, Bayer AG has been instructed by a jury to pay a staggering $100 million in damages attributed to the contamination caused by polychlorinated biphenyls (PCBs) in residential areas. This ruling comes as part of a larger trend of litigation surrounding the chemical's legacy, which has plagued communities and sparked environmental health concerns across the United States.
Continue reading